ArticleNature communications2026
Dissecting epigenetic heterogeneity in single-cell DNA methylomes with a unified framework.
Article in Nature communications, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- SMORE: joint dimension reduction and cell population discovery on single-cell methylome data.bioRxiv : the preprint server for biology · 2026Article
- MethyAnno: An Interpretable Automated Annotation Method Leveraging Multi-Scale Information and Metric Learning Framework for scDNAm Data.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026Article
- Dissecting epigenetic heterogeneity in single-cell DNA methylomes with a unified framework.Nature communications · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Single-cell DNA methylation (scDNAm) sequencing offers unprecedented opportunities for dissecting epigenetic heterogeneity and gene regulatory mechanisms. However, most existing analytical methods are adapted from conventional single-cell sequencing frameworks, such as single-cell RNA sequencing, and fail to account for the unique characteristics of scDNAm data, including the widespread presence of explicit missing values and their distinct distribution patterns. To enable systematic exploration of DNA methylation-derived epigenetic variation at single-cell resolution, we propose scMethCraft, a versatile analytical toolkit. scMethCraft integrates multi-perspective genomic sequence features and position information of methylated regions via a hybrid neural network, and iteratively quantifies the cell-to-cell associations, enabling accurate modeling of scDNAm data. scMethCraft facilitates accurate reconstruction of DNA methylation landscapes and supports a spectrum of downstream analyses, including cell embedding, multi-source data integration, cell type annotation, epigenetic signal enhancement, and identification of differentially methylated regions, thereby significantly facilitating the identification and characterization of scDNAm heterogeneity. The integration of scMethCraft with complementary analytical workflows, including biological function enrichment, tissue-specific expression analysis, and partitioned heritability assessment, enables the discovery of biological insights into specific cellular subpopulations. Furthermore, scMethCraft identified oligodendrocyte-associated genes that are not well characterized in existing databases, providing an epigenetic perspective for investigating underlying biological mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.